Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Neoantigen-directed immune escape in lung cancer evolution.

Rosenthal R, Cadieux EL, Salgado R, Bakir MA, Moore DA, Hiley CT, Lund T, Tanić M, Reading JL, Joshi K, Henry JY, Ghorani E, Wilson GA, Birkbak NJ, Jamal-Hanjani M, Veeriah S, Szallasi Z, Loi S, Hellmann MD, Feber A, Chain B, Herrero J, Quezada SA, Demeulemeester J, Van Loo P, Beck S, McGranahan N, Swanton C; TRACERx consortium.

Nature. 2019 Mar;567(7749):479-485. doi: 10.1038/s41586-019-1032-7. Epub 2019 Mar 20.

PMID:
30894752
2.

Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.

Arce Vargas F, Furness AJS, Litchfield K, Joshi K, Rosenthal R, Ghorani E, Solomon I, Lesko MH, Ruef N, Roddie C, Henry JY, Spain L, Ben Aissa A, Georgiou A, Wong YNS, Smith M, Strauss D, Hayes A, Nicol D, O'Brien T, Mårtensson L, Ljungars A, Teige I, Frendéus B; TRACERx Melanoma; TRACERx Renal; TRACERx Lung consortia, Pule M, Marafioti T, Gore M, Larkin J, Turajlic S, Swanton C, Peggs KS, Quezada SA.

Cancer Cell. 2018 Apr 9;33(4):649-663.e4. doi: 10.1016/j.ccell.2018.02.010. Epub 2018 Mar 22.

3.

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.

Arce Vargas F, Furness AJS, Solomon I, Joshi K, Mekkaoui L, Lesko MH, Miranda Rota E, Dahan R, Georgiou A, Sledzinska A, Ben Aissa A, Franz D, Werner Sunderland M, Wong YNS, Henry JY, O'Brien T, Nicol D, Challacombe B, Beers SA; Melanoma TRACERx Consortium; Renal TRACERx Consortium; Lung TRACERx Consortium, Turajlic S, Gore M, Larkin J, Swanton C, Chester KA, Pule M, Ravetch JV, Marafioti T, Peggs KS, Quezada SA.

Immunity. 2017 Apr 18;46(4):577-586. doi: 10.1016/j.immuni.2017.03.013. Epub 2017 Apr 11.

4.

The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells.

Menezes S, Melandri D, Anselmi G, Perchet T, Loschko J, Dubrot J, Patel R, Gautier EL, Hugues S, Longhi MP, Henry JY, Quezada SA, Lauvau G, Lennon-Duménil AM, Gutiérrez-Martínez E, Bessis A, Gomez-Perdiguero E, Jacome-Galarza CE, Garner H, Geissmann F, Golub R, Nussenzweig MC, Guermonprez P.

Immunity. 2016 Dec 20;45(6):1205-1218. doi: 10.1016/j.immuni.2016.12.001.

5.

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.

McGranahan N, Furness AJ, Rosenthal R, Ramskov S, Lyngaa R, Saini SK, Jamal-Hanjani M, Wilson GA, Birkbak NJ, Hiley CT, Watkins TB, Shafi S, Murugaesu N, Mitter R, Akarca AU, Linares J, Marafioti T, Henry JY, Van Allen EM, Miao D, Schilling B, Schadendorf D, Garraway LA, Makarov V, Rizvi NA, Snyder A, Hellmann MD, Merghoub T, Wolchok JD, Shukla SA, Wu CJ, Peggs KS, Chan TA, Hadrup SR, Quezada SA, Swanton C.

Science. 2016 Mar 25;351(6280):1463-9. doi: 10.1126/science.aaf1490. Epub 2016 Mar 3.

6.

TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells.

Menger L, Gouble A, Marzolini MA, Pachnio A, Bergerhoff K, Henry JY, Smith J, Pule M, Moss P, Riddell SR, Quezada SA, Peggs KS.

Blood. 2015 Dec 24;126(26):2781-9. doi: 10.1182/blood-2015-08-664755. Epub 2015 Oct 27.

PMID:
26508783
7.

CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status.

Sellar RS, Vargas FA, Henry JY, Verfuerth S, Charrot S, Beaton B, Chakraverty R, Quezada SA, Mackinnon S, Thomson KJ, Peggs KS.

Blood. 2015 Jan 22;125(4):731-9. doi: 10.1182/blood-2014-07-589150. Epub 2014 Dec 12.

PMID:
25499763
8.

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.

Simpson TR, Li F, Montalvo-Ortiz W, Sepulveda MA, Bergerhoff K, Arce F, Roddie C, Henry JY, Yagita H, Wolchok JD, Peggs KS, Ravetch JV, Allison JP, Quezada SA.

J Exp Med. 2013 Aug 26;210(9):1695-710. doi: 10.1084/jem.20130579. Epub 2013 Jul 29.

9.

Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide.

Henry JY, Labarthe MC, Meyer B, Dasgupta P, Dalgleish AG, Galustian C.

Immunology. 2013 Jul;139(3):377-85. doi: 10.1111/imm.12087.

10.

Revealing the insulating gap in α'-NaV (2)O(5) with resonant inelastic x-ray scattering.

Bondino F, Barla A, Schmitt T, Strocov VN, Henry JY, Sanchez JP.

J Phys Condens Matter. 2012 Aug 15;24(32):325402, 1-5. doi: 10.1088/0953-8984/24/32/325402. Epub 2012 Jul 18.

PMID:
22809788
11.

Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.

Henry JY, Lu L, Adams M, Meyer B, Bartlett JB, Dalgleish AG, Galustian C.

Prostate. 2012 Jun 1;72(8):856-67. doi: 10.1002/pros.21488. Epub 2011 Oct 3.

PMID:
21968939
12.

Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs).

Liu WM, Henry JY, Meyer B, Bartlett JB, Dalgleish AG, Galustian C.

Br J Cancer. 2009 Sep 1;101(5):803-12. doi: 10.1038/sj.bjc.6605206. Epub 2009 Jul 28.

13.

A microarray study of altered gene expression in colorectal cancer cells after treatment with immunomodulatory drugs: differences in action in vivo and in vitro.

Liu WM, Laux H, Henry JY, Bolton TB, Dalgleish AG, Galustian C.

Mol Biol Rep. 2010 Apr;37(4):1801-14. doi: 10.1007/s11033-009-9614-3. Epub 2009 Jul 14.

PMID:
19597962
14.

Nuclear-spin-lattice relaxation rate of planar oxygen in YBa2Cu3O6.52 and YBa1.92Sr0.08Cu3O7 single crystals.

Horvatic M, Berthier C, Berthier Y, Ségransan P, Butaud P, Clark WG, Gillet JA, Henry JY.

Phys Rev B Condens Matter. 1993 Nov 1;48(18):13848-13864. No abstract available.

PMID:
10007787
15.

Superconductivity-induced phonon softening in YBa2Cu3O7 observed by inelastic neutron scattering.

Pyka N, Reichardt W, Pintschovius L, Engel G, Rossat-Mignod J, Henry JY.

Phys Rev Lett. 1993 Mar 8;70(10):1457-1460. No abstract available.

PMID:
10053297
16.

NMR investigation of single-crystal YBa2Cu3O6+x from the underdoped to the overdoped regime.

Horvatic M, Auler T, Berthier C, Berthier Y, Butaud P, Clark WG, Gillet JA, Ségransan P, Henry JY.

Phys Rev B Condens Matter. 1993 Feb 1;47(6):3461-3464. No abstract available.

PMID:
10006443
17.

Thermal conductivity of Nd1.85Ce0.15CuO4.

Núez Regueiro M, Salce B, Calemczuk R, Marin C, Henry JY.

Phys Rev B Condens Matter. 1991 Nov 1;44(17):9727-9730. No abstract available.

PMID:
9998965
18.

Positron annihilation on single crystals of YBa2Cu3O7-x.

Barbiellini B, Genoud P, Henry JY, Hoffmann L, Jarlborg T, Manuel AA, Massidda S, Peter M, Sadowski W, Scheel HJ, Shukla A, Singh AK, Walker E.

Phys Rev B Condens Matter. 1991 Apr 1;43(10):7810-7825. No abstract available.

PMID:
9996400
19.

Anisotropic specific-heat behavior under a magnetic field of a YBa2Cu3O7 single crystal.

Bonjour E, Calemczuk R, Henry JY, Khoder AF.

Phys Rev B Condens Matter. 1991 Jan 1;43(1):106-109. No abstract available.

PMID:
9996195
20.

NMR evidence for localized spins on Cu(2) sites from Cu NMR in YBa2Cu3O7 and YBa2Cu3O6.75 single crystals.

Horvatic M, Ségransan P, Berthier C, Berthier Y, Butaud P, Henry JY, Couach M, Chaminade JP.

Phys Rev B Condens Matter. 1989 Apr 1;39(10):7332-7335. No abstract available.

PMID:
9947402
21.

Staircase superconducting structure and oxygen intercalation in YBa2Cu3O7- delta single crystals.

Couach M, Khoder AF, Monnier F, Barbara B, Henry JY.

Phys Rev B Condens Matter. 1988 Jul 1;38(1):748-751. No abstract available.

PMID:
9945244
22.

[Pubo-abdominal pathology in the athlete. Value of bone scintigraphy with technetium 99m labelled methylene diphosphonate].

Rochcongar P, Le Jeune JJ, Henry JY, Moisan A.

Nouv Presse Med. 1980 Jul 12-26;9(30):2084. French. No abstract available.

PMID:
6447277
23.

[Changes in pulmonary circulation during drug-induced bronchospasm (data on pulmonary scintigraphy with MAI 131)].

Laval P, Feliciano JM, Rosello R, Henry JY.

Mars Med. 1969;106(11):913-7. French. No abstract available.

PMID:
5407171

Supplemental Content

Loading ...
Support Center